Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Complication in Systemic Lupus Erythematosus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT07678203
What this trial is testing

Dapagliflozin to Reduce the Decline in Renal Function in Patients Newly Diagnosed With Lupus Nephritis

Who this might be right for
Lupus Nephritis (LN)Chronic Kidney DiseaseSGLT 2 Inhibitors+1 more
Hospital Civil Juan I. Menchaca 30
Not applicableStudy completedNCT04870359
What this trial is testing

Pre-emptive Treatments in Lupus Nephritis Patients With Serological Reactivation

Who this might be right for
Lupus Nephritis
The University of Hong Kong 49
Large-scale testing (Phase 3)Ended earlyNCT01714817
What this trial is testing

Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

Who this might be right for
Lupus Nephritis
Bristol-Myers Squibb 695
Not applicableStudy completedNCT00881309
What this trial is testing

To Compare the Efficacy and Safety of Tripterygium (TW) Versus AZA in the Maintenance Therapy for Lupus Nephritis

Who this might be right for
Lupus Nephritis
Nanjing University School of Medicine 94
Early research (Phase 1)Active Not RecruitingNCT06294236
What this trial is testing

Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)

Who this might be right for
Lupus ErythematosusSystemic Lupus ErythematosusSLE (Systemic Lupus)+3 more
Sana Biotechnology 7
Not applicableLooking for participantsNCT06642402
What this trial is testing

Monitoring Lupus Nephritis Through Urinary Extracellular Vesicles

Who this might be right for
Systemic Lupus Erythematosus Nephritis
Kolding Sygehus 40
Testing effectiveness (Phase 2)Looking for participantsNCT06155604
What this trial is testing

SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease

Who this might be right for
Lupus NephritisChronic Kidney Diseases
The University of Hong Kong 150
Large-scale testing (Phase 3)Active Not RecruitingNCT05138133
What this trial is testing

Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
AstraZeneca 363
Early research (Phase 1)Looking for participantsNCT07109986
What this trial is testing

UB-VV410 in Subjects With Active Refractory Systemic Lupus Erythematosus or Lupus Nephritis

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Nanjing IASO Biotechnology Co., Ltd. 21
Not applicableUnknownNCT03791827
What this trial is testing

Multicenter Registry of Pediatric Lupus Nephritis in China

Who this might be right for
Lupus NephritisChildrenSteroid+1 more
Xiqiang Dang 1,200
Large-scale testing (Phase 3)Not Yet RecruitingNCT07767188
What this trial is testing

A Trial to Explore the Efficacy and Safety of O-triple as Initial Therapy in the Active Lupus Nephritis Patients (INITIAL Trial)

Who this might be right for
Lupus Nephritis
Zhao Minghui 70
Early research (Phase 1)UnknownNCT05566977
What this trial is testing

Autologous Adoptive T Regulatory Cell Transfer in Autoimmune Diseases.

Who this might be right for
Lupus NephritisType 1 Diabetes Mellitus
Ain Shams University 20
Early research (Phase 1)WithdrawnNCT06984341
What this trial is testing

Evaluate the Safety, Tolerability, Cellular Kinetics, Pharmacodynamics, and Efficacy of P-CD19CD20-ALLO1 in Participants With Severe, Treatment-refractory Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Genentech, Inc.
Early research (Phase 1)Looking for participantsNCT07115745
What this trial is testing

Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

Who this might be right for
Refractory Autoimmune Diseases
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 125
Testing effectiveness (Phase 2)Looking for participantsNCT06121297
What this trial is testing

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Cabaletta Bio 28
Testing effectiveness (Phase 2)Study completedNCT03453619
What this trial is testing

Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies

Who this might be right for
IgA NephropathyLupus NephritisMembranous Nephropathy+2 more
Apellis Pharmaceuticals, Inc. 21
Large-scale testing (Phase 3)Study completedNCT00282347
What this trial is testing

Evaluate the Efficacy and Safety of Rituximab in Subjects With International Society of Nephrology/Renal Pathology Society (ISN/RPS) 2003 Class III or IV Lupus Nephritis

Who this might be right for
Lupus Nephritis
Genentech, Inc. 144
Large-scale testing (Phase 3)Study completedNCT03597464
What this trial is testing

Aurinia Renal Assessments 2: Aurinia Renal Response in Lupus With Voclosporin

Who this might be right for
Lupus Nephritis
Aurinia Pharmaceuticals Inc. 216
Large-scale testing (Phase 3)UnknownNCT04892212
What this trial is testing

Sirolimus in Treatment of Proteinuric Flares of Lupus Nephritis

Who this might be right for
Lupus NephritisImmunosuppressionEffect of Drug
Peking Union Medical College Hospital 20
Not applicableUnknownNCT04320797
What this trial is testing

Urinary T Cell Biomarker for Prediction in Lupus Nephritis

Who this might be right for
Lupus Nephritis
Charite University, Berlin, Germany 79
Next Page